CELLDEX THERAPEUTICS INC NEW

CUSIP: 15117B103 Class: COM

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2018
Shares 68,194 Value ($000) $14 Avg Close Range
Q3 2018
Shares 3,094 Value ($000) $1 Avg Close Range
Q2 2018
Shares 65,905 Value ($000) $33 Avg Close Range
Q1 2018
Shares 34,834 Value ($000) $81 Avg Close Range
Q4 2017
Shares 35,367 Value ($000) $100 Avg Close Range
Q3 2017
Shares 76,362 Value ($000) $219 Avg Close Range
Q2 2017
Shares 65,739 Value ($000) $162 Avg Close Range
Q1 2017
Shares 73,078 Value ($000) $264 Avg Close Range
Q4 2016
Shares 191,047 Value ($000) $677 Avg Close Range
Q3 2016
Shares 150,237 Value ($000) $607 Avg Close Range
Q2 2016
Shares 233,834 Value ($000) $1,027 Avg Close Range
Q1 2016
Shares 68,021 Value ($000) $257 Avg Close Range
Q4 2015
Shares 255,504 Value ($000) $4,006 Avg Close Range
Q3 2015
Shares 71,701 Value ($000) $756 Avg Close Range
Q2 2015
Shares 83,583 Value ($000) $2,108 Avg Close Range
Q1 2015
Shares 79,878 Value ($000) $2,226 Avg Close Range
Q4 2014
Shares 58,016 Value ($000) $1,059 Avg Close Range